Skip to main content
. 2012 Sep 10;20(1):34. doi: 10.1186/2008-2231-20-34

Table 2.

Adverse Drug Reactions and the suspected antihypertensive medicine

Suspected Drugs (No. of Prescriptions) ADRs Experienced No. of ADRs (%*) Interventions
Calcium Channel Blockers
Amlodipine (68)
Ankle edema
02 (2.94%)
Dechallenge
 
Abdominal pain
02 (2.94%)
Symptomatic treatment
 
Sedation
01 (1.47%)
Symptomatic treatment
 
Pedal edema
01 (1.47%)
Symptomatic treatment
 
Back pain
01 (1.47%)
Symptomatic treatment
Total
 
07 (10.29%)
 
Diuretics
Torasemide (18)
Fatigue
01 (5.55%)
Symptomatic treatment
 
Visual impairment
01 (5.55%)
Dechallenge
 
Dizziness
01 (5.55%)
No change in treatment
Total
 
03 (16.66%)
 
Amiloride (09)
Dizziness
01 (11.11%)
No change in treatment
 
Loss of appetite
01 (11.11%)
Symptomatic treatment
Total
 
02 (22.22%)
 
Grand Total
 
05 (18.51%)
 
ACE Inhibitors
Ramipril (33)
Dry cough
02 (6.06%)
Dechallenge
Total
 
02 (6.06%)
 
Angiotensine Receptor Blockers
Telmisartan (17)
Dizziness
01 (5.88%)
No change in treatment
Losartan (22)
Dizziness
01 (4.54%)
No change in treatment
Olmesartan (06)
Dizziness
01 (16.66%)
No change in treatment
Total
 
03 (6.66%)
 
Beta-blockers
Atenolol (34)
Bradycardia
01 (2.94%)
No change in treatment
Metoprolol (12)
Headache
01 (8.33%)
No change in treatment
Propranolol (20)
Insomnia
01 (5.00%)
Dechallenge
 
Depression
01 (5.00%)
Dechallenge
Total   04 (6.06%)  

*The percentage of ADRs was calculated from no of prescriptions of suspected drug.